Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 20.09.2024
BRAIN Biotech AG
BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Total transaction value up to EUR 128.88 million significantly exceeding current market capitalization of BRAIN Biotech
Immediate upfront payment of EUR 18.41 million
Royalty monetization of an investigational compound, deucrictiban [ … ]
Fri, 20.09.2024
BRAIN Biotech AG
BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Total transaction value up to EUR 128.88 million significantly exceeding current market capitalization of BRAIN Biotech
Immediate upfront payment of EUR 18.41 million
Royalty monetization of an investigational compound, deucrictiban [ … ]
Fri, 20.09.2024
BRAIN Biotech AG
NOT FOR DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR DISSEMINATION WOULD BE UNLAWFUL. OTHER RESTRICTIONS APPLY. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.
BRAIN Biotech AG concludes royalty monetization d [ … ]
Fri, 20.09.2024
BRAIN Biotech AG
NOT FOR DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR DISSEMINATION WOULD BE UNLAWFUL. OTHER RESTRICTIONS APPLY. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.
BRAIN Biotech AG concludes royalty monetization d [ … ]
Fri, 20.09.2024
Evotec SE
J.POD® Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the region
Just – Evotec Biologics’ J.POD® technology offers a paradigm shift in biomanufacturing with cost-effective and flexible clinical and commercial supply solutions
Hamburg, Germany, and Toulouse, France, 20 Septemb [ … ]
Fri, 20.09.2024
Evotec SE
J.POD® Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the region
Just – Evotec Biologics’ J.POD® technology offers a paradigm shift in biomanufacturing with cost-effective and flexible clinical and commercial supply solutions
Hamburg, Germany, and Toulouse, France, 20 Septemb [ … ]
Fri, 20.09.2024
asknet Solutions AG
EQS-Media / 20.09.2024 / 15:14 CET/CEST
20th of September, Karlsruhe, 2024 – Academic Software, the software entity of Signpost, takes a major step into the DACH educational market with the acquisition of asknet GmbH, Germany’s leading provider of academic software solutions.
For Academic Software, this acquisition represents a significant a [ … ]
Fri, 20.09.2024
asknet Solutions AG
EQS-Media / 20.09.2024 / 15:14 CET/CEST
20th of September, Karlsruhe, 2024 – Academic Software, the software entity of Signpost, takes a major step into the DACH educational market with the acquisition of asknet GmbH, Germany’s leading provider of academic software solutions.
For Academic Software, this acquisition represents a significant a [ … ]
Fri, 20.09.2024
The NAGA Group AG
The NAGA Group: Research update from NuWays available – “BUY” recommendation confirmed and price target raised to EUR 1.40
Rating: BUYPrice target: EUR 1.40Upside to current share price: 30%Hamburg, 20 September 2024 – The price target of The NAGA Group AG (XETRA: N4G, ISIN: DE000A161NR7) is raised to EUR 1.40 (previously: EUR 1.20) in the latest r [ … ]
Fri, 20.09.2024
The NAGA Group AG
The NAGA Group: Research update from NuWays available – “BUY” recommendation confirmed and price target raised to EUR 1.40
Rating: BUYPrice target: EUR 1.40Upside to current share price: 30%Hamburg, 20 September 2024 – The price target of The NAGA Group AG (XETRA: N4G, ISIN: DE000A161NR7) is raised to EUR 1.40 (previously: EUR 1.20) in the latest r [ … ]